Corona vaccine under development in the UK Confirms immune response in all age groups and announces November 19 at 11:33 p.m.
Oxford University in the UK has published research results that show that the immune response of the new coronavirus vaccine, which is being developed with pharmaceutical giant AstraZeneca, has been confirmed in all age groups, including the elderly.
Oxford University is developing a vaccine for the new coronavirus with AstraZeneca, and the results of the second of the three-stage clinical trial were published today in the British medical journal L’Anset.
As a result, we vaccinated 560 healthy people over the age of 18 and found immune responses in all age groups.
The immune response was confirmed in much the same way as younger people, even in people over the age of 56, including the elderly.
The research group says it is “encouraging” because the risk of severe disease with the new coronavirus is higher in the elderly.
The research group wants to draw a conclusion next month on whether the vaccine is effective in preventing infection, based on the final trials currently underway.